Among these patients, six individuals (24%) had a medical history of hypertension and were managed pharmacologically with beta-blockers and angiotensin-converting enzyme inhibitors (ACEI)/angiotensin II receptor blockers (ARBs). Here, ACE is linked to hypertensive disorder.